scholarly article | Q13442814 |
P50 | author | Antonio Angel Regueiro Martínez | Q80146001 |
P2093 | author name string | Alfonso Otero | |
Sonia Lorenzo | |||
Artemio Mojón | |||
Diana E Ayala | |||
Ramón C Hermida | |||
Juan J Crespo | |||
María T Ríos | |||
Hygia Project Investigators | |||
Luis Piñeiro | |||
Carmen Castiñeira | |||
P2860 | cites work | Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects | Q22254619 |
A new equation to estimate glomerular filtration rate | Q24651973 | ||
Chronotherapy of hypertension | Q28210366 | ||
Diagnosis and classification of diabetes mellitus | Q28280909 | ||
Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep | Q28295136 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
Comparison of parameters from rhythmometric models with multiple components on hybrid data | Q30954476 | ||
Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls | Q30981168 | ||
Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease | Q33546228 | ||
Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. | Q34652165 | ||
Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. | Q35043269 | ||
Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. | Q35758267 | ||
Oxidative stress in essential hypertension | Q35768622 | ||
Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study | Q57085488 | ||
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality | Q57085545 | ||
Out-of-hospital sudden death referring to an emergency department | Q57987986 | ||
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension | Q57988042 | ||
Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients | Q58950072 | ||
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension | Q36053212 | ||
Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure | Q36208677 | ||
Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. | Q36769612 | ||
Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure | Q36894839 | ||
Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy | Q36894865 | ||
Out-of-office blood pressure monitoring in chronic kidney disease | Q37385751 | ||
Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes | Q37435002 | ||
Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. | Q37767111 | ||
Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. | Q37798715 | ||
Ethics and methods for biological rhythm research on animals and human beings | Q37802394 | ||
Circadian rhythms and cardiovascular health. | Q37884999 | ||
Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus | Q40759388 | ||
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study | Q40804261 | ||
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension | Q41009546 | ||
Endocrine mechanisms of blood pressure rhythms. | Q41149087 | ||
Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing | Q42960996 | ||
Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension | Q43044200 | ||
Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension | Q43624001 | ||
Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk | Q43759322 | ||
Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension | Q43892602 | ||
Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease | Q44083658 | ||
Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients | Q44474451 | ||
Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects | Q44521145 | ||
Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study | Q44648549 | ||
Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes | Q45116862 | ||
Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study | Q45204771 | ||
Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study | Q45559214 | ||
Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. | Q46015855 | ||
Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. | Q46016911 | ||
Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients | Q46163937 | ||
Prognostic influence of office and ambulatory blood pressures in resistant hypertension | Q46231193 | ||
Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients | Q46312892 | ||
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients | Q46620895 | ||
Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy | Q47665584 | ||
Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes | Q48210138 | ||
Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension | Q48273841 | ||
Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing | Q48289407 | ||
Correlates of systolic hypertension in patients with chronic kidney disease | Q48539717 | ||
Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis | Q48661397 | ||
Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients | Q48661509 | ||
Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure | Q48933021 | ||
Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. | Q50753696 | ||
Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects | Q50868018 | ||
Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. | Q51943135 | ||
Tables | Q56385764 | ||
2007 Guidelines for the Management of Arterial Hypertension | Q56970780 | ||
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations | Q57085408 | ||
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study | Q57085479 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 159-175 | |
P577 | publication date | 2012-10-25 | |
P1433 | published in | Chronobiology International | Q2025696 |
P1476 | title | Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease | |
P478 | volume | 30 |
Q44360459 | 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals |
Q47765005 | Altered circadian hemodynamic and renal function in cirrhosis |
Q47916747 | Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults |
Q92059307 | Ambulatory blood pressure monitoring-based analysis of long-term outcomes for kidney disease progression |
Q38208966 | Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk |
Q39541406 | Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox |
Q38177166 | Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders. |
Q64913459 | Chronotherapy for Hypertension. |
Q39008905 | Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients |
Q38100986 | Chronotherapy improves blood pressure control and reduces vascular risk in CKD. |
Q47910182 | Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks |
Q100472612 | Circadian Variation in Efficacy of Medications |
Q45986217 | Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. |
Q91133844 | Circadian rhythms and the kidney |
Q48213872 | Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk |
Q38045905 | Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. |
Q48210138 | Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes |
Q39329895 | Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis |
Q30371562 | Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms. |
Q35651663 | Management of hypertension in CKD: beyond the guidelines |
Q90463927 | Normotensive non-dipping blood pressure profile does not predict the risk of chronic kidney disease progression |
Q35013404 | Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU |
Q34580946 | Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease |
Q47853674 | Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project |
Q36100474 | The complex relationship between CKD and ambulatory blood pressure patterns |
Search more.